What the FDA labels say about taking them together
Heparin and telavancin
Telavancin's FDA label of December 19, 2025 names heparin in its contraindications section; the heparin labels PlainMeds reads (4) do not name telavancin.
Check it at the source: the heparin FDA label on DailyMed (effective November 28, 2025, Fresenius Kabi USA, LLC); the telavancin FDA label on DailyMed (effective December 19, 2025, Cumberland Pharmaceuticals Inc.).
What does the heparin label say about telavancin?
Heparin's label (effective November 28, 2025) and its 3 other brand-application labels do not name telavancin in these sections. A label lists what its studies and reports found; it is not a complete list.
Source: FDA drug label (Heparin Sodium), Fresenius Kabi USA, LLC, effective November 28, 2025 (SPL set d55b4a63-0c04-4874-b74f-9e9b9e8b008c), via openFDA; the full label on DailyMed
What does the telavancin label say about heparin?
Telavancin label, contraindicationsCONTRAINDICATIONS Intravenous Unfractionated Heparin Sodium ( 4.1 , 5.5 , 7.1 ) Known hypersensitivity to VIBATIV
Source: FDA drug label (VIBATIV), NDA022110 (Apotex), as published by Cumberland Pharmaceuticals Inc., effective December 19, 2025 (SPL set 5359b759-db7c-4672-9e8a-59c93869bd91), via openFDA; the full label on DailyMed
These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.
Both medicines on the record
| Heparin | Telavancin | |
|---|---|---|
| Labeled for | Blood clots (DVT and PE), Atrial fibrillation | n/a |
| Boxed warning | No | Yes |
| Pharmacy cost (NADAC) | $1.18 per mL 5,000 unit/mL vial | n/a |
| Shortage now | In shortage | No current entry |
Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)
What next?
- Check more medicines together
- up to five at once